Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review protocol by Sarah Maheux-Lacroix et al.
Maheux-Lacroix et al. Systematic Reviews 2013, 2:50
http://www.systematicreviewsjournal.com/content/2/1/50PROTOCOL Open AccessHysterosalpingosonography for diagnosing tubal
occlusion in subfertile women: a systematic
review protocol
Sarah Maheux-Lacroix1,2*, Amélie Boutin2, Lynne Moore2, Marie-Ève Bergeron1,2, Emmanuel Bujold1,2,
Philippe Y Laberge1,2, Madeleine Lemyre1,2 and Sylvie Dodin1,2Abstract
Background: Hysterosalpingosonography has been suggested as a less invasive alternative to
hysterosalpingography for detecting tubal occlusion among subfertile women. We aim to determine the diagnostic
accuracy of hysterosalpingosonography and to compare it to hysterosalpingography.
Methods/design: We will conduct a systematic review of diagnostic test accuracy. We will search Medline, Embase,
Cochrane Library, Web of Science and Biosis, as well as reference lists of included studies and previous related
review articles. Diagnostic studies that compared hysterosalpingosonography ± hysterosalpingography to
laparoscopy with chromotubation in women suffering from subfertility will be eligible. Two authors will
independently screen for inclusion, data extraction, and quality assessment. Methodological quality will be assessed
using the Quality Assessment of Diagnostic Accuracy Study 2 tool (QUADAS-2). We will use SAS 9.3 (SAS Institute
Inc., Cary, NC, USA, 2011) to program bivariate random-effects models, estimate pooled sensitivity and specificity
with 95% confidence intervals and to generate summary receiver operating characteristics curves. We will perform
sensitivity analyses to examine the effect of differences in techniques used for hysterosalpingosonography and in
methodological quality of studies.
Discussion: This systematic review will help to determine if hysterosalpingosonography is an adequate alternative
screening test for diagnosing tubal occlusion. Accuracy of specific sono-HSG techniques may also be identified.
Trial registration: This review has been registered at PROSPERO. The registration number is CRD42013003829.
Keywords: Hysterosalpingosonography, HyCoSy, Hysterosalpingography, Tubal patency, Subfertility, Diagnostic test
accuracy, Systematic review, Meta-analysisBackground
Tubal factors are responsible for approximately one third
of female subfertility [1]. Screening for tubal occlusion is
part of the investigation of subfertile couples and is
classically performed using hysterosalpingography (HSG)
or laparoscopy with chromotubation [2]. Laparoscopy is
largely accepted as the gold standard for diagnosing tubal
occlusion [2-4]. However, being a more costly and invasive
test [3], it is usually reserved for women who could also* Correspondence: sarah.maheux-lacroix.1@ulaval.ca
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distribution, and reproduction in any mediumbenefit from laparoscopy for the assessment or treatment
of another pelvic pathology [2]. Conversely, in women
without suspected comorbidities (such as pelvic inflamma-
tory disease, previous ectopic pregnancy or endometriosis),
HSG is largely accepted as a valid test for ruling out tubal
occlusion [2].
More recently, hysterosalpingosonography (sono-HSG),
an ultrasound-based technique, was proposed as another
minimally invasive alternative to laparoscopy. Sono-HSG
and HSG are both outpatient procedures that are well
tolerated [5-7]. However, sono-HSG has the advantages of
avoiding the use of ionizing radiation and the risk of
iodine allergy [3]. Compared to HSG, sono-HSG also has
greater sensitivity and specificity for detecting intrauterineCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the ovaries and the myometrium [3].
A previous systematic review with meta-analysis
comparing sono-HSG and HSG to laparoscopy for
diagnosing tubal occlusion was published in 1997 [10].
In this review, sono-HSG was associated with a 10% rate
of false occlusion and 7% of false patency compared to
13% and 11%, respectively, with HSG. However, several
reports have been published after this review [3]. Over the
years, the techniques for sono-HSG have been improved
with the arrival of new contrast media, three-dimensional
(3D) ultrasonography, color-coded 3D power Doppler
imaging, and increasing resolution of ultrasound [11-13].
The primary objective of our study is to determine
the diagnostic accuracy of sono-HSG for detecting
tubal occlusion in women suffering from subfertility.
The secondary objective is to compare the diagnostic
accuracy of sono-HSG and HSG in reference to laparos-
copy with chromotubation. We plan to investigate sources
of heterogeneity such as differences in the techniques used
to perform sono-HSG and methodological quality of the
included studies.Methods
Design
The design of this systematic review was elaborated by
a multidisciplinary group of experts (for example,
reproductive endocrinology and infertility, sonography in
obstetrics and gynecology, minimally invasive gynecology,
research methodology) using methodological approaches
outlined in the Cochrane Handbook for Systematic
Review of Diagnostic Test Accuracy [14]. This protocol was
written in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
[15] criteria and has been registered with PROSPERO
(#CRD42013003829).Information sources and search strategy
We will search Medline, Embase, Cochrane Library,
and the Web of Science from their inception. Biosis
will be used to identify relevant abstracts and confer-
ence proceedings. The search strategy for Pubmed is
presented in Table 1. As recommended in the litera-
ture [16-18], we developed search strategies with terms
related to the index test (sono-HSG) and the target
condition (tubal occlusion) and did not use any filter
for diagnostic studies to maximize the sensitivity of
the search strategies. All strategies were revised by a
healthcare librarian and all authors. Finally, we will
look at reference lists and citations of relevant articles
(previous reviews and included studies) to identify any
additional eligible studies.Eligibility criteria and study selection
We will consider all studies assessing the diagnostic accur-
acy of sono-HSG for diagnosing tubal occlusion among a
subfertile population. There will be no restriction in terms
of publication date or language. Studies published in
languages other than English or French will be translated.
Studies including women suffering from recurrent spon-
taneous miscarriages will be eligible. However, we will
exclude studies that include populations having no desire
for fertility (for example, assessment of tubal occlusion
after a hysteroscopic tubal occlusion procedure).
Laparoscopy with chromotubation is widely recognized
as the gold standard in assessing tubal patency [2,3] as its
findings are highly correlated with spontaneous pregnancy
rate [4]. Thus, we will consider exclusively studies using
laparoscopy as reference standard. Studies considering
other modalities as gold standard, such as HSG, hyster-
oscopic selective tubal cannulation under fluoroscopic
guidance or vaginal laparoscopy, will be excluded [19].
For studies using HSG as a comparator test (that is,
additionally assessing the accuracy of HSG compared to
laparoscopy), data on the diagnostic accuracy of HSG
will be retained in order to make a direct comparison of
accuracy between sono-HSG and HSG.
We will consider consecutive and random series of
patients as well as case-control designs. For studies using
partial verification (gold standard achieved only in a
subgroup of participants), we proceeded according to
recent recommendations [20,21]. Studies with partial
verification will not be systematically excluded in order to
obtain an increased precision and a better generalizability.
Studies using a random partial verification will be included
as they are not prone to the partial verification bias. In
cases of non-random partial verification, studies will be
included in the review only if adjustment for the verification
bias is possible. That is, if determinants of the partial
verification are known and verification in each strata is
random and in known proportions.
Eligibility assessment will be performed independently
by two reviewers screening titles, abstracts, and full text
publications, when required. If disagreements are not
resolved by consensus, a third reviewer will be consulted.
We will collect reasons for full-text exclusion. To avoid
duplication, author names, sample sizes and results of
studies will be compared.
Data collection
Two reviewers will extract data from included studies
and disagreements will be resolved by discussion. If
consensus is not reached, a third reviewer will be consulted.
We developed a standardized data abstraction form, which
was pilot-tested on three studies [22-24] and refined
accordingly. The following information will be extracted
from each study:
Table 1 Pubmed search strategy (results from 14th November, 2012)
Search Results
#1 Fallopian Tube Patency Tests [Mesh] OR Hysterosalpingo-contrast-sonography [tiab] OR “Hysterosalpingo-contrast
sonography” [tiab] OR “Hysterosalpingo contrast sonography” [tiab] OR Hysterosalpingo-contrast-ultrasonography
[tiab] OR “Hysterosalpingo-contrast ultrasonography” [tiab] OR “Hysterosalpingo contrast ultrasonography” [tiab] OR
Hysterosalpingo-foam-sonography [tiab] OR “Hysterosalpingo-foam sonography” [tiab] OR “Hysterosalpingo foam
sonography” [tiab] OR Hysterosalpingosonography [tiab] OR Hysterosonosalpingography [tiab] OR
Sonohysterosalpingography [tiab] OR HyCoSy [tiab] OR HyFoSy [tiab] OR Sono-HSG [tiab] OR SonoHSG [tiab] OR
“Sono HSG” [tiab] OR Ultrasonography [Mesh] OR *Ultrasound* [tiab] OR *Sonogra* [tiab] OR *Ultrason* [tiab] OR
*Echograph* [tiab]
387435
#2 Fallopian tube diseases [Mesh] OR ((Fallopian tubes [Mesh] OR Tubal [tiab] OR tube [tiab] OR tubes [tiab]) AND
(patenc* [tiab] OR block* [tiab] OR occlusi* [tiab] OR obstructi* [tiab] OR damage* [tiab])
15021
#3 Animals [Mesh] NOT Humans [Mesh] 3728027
#4 #1 AND #2 AND #3 962
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inclusion and exclusion criteria, flow diagram,
setting, country, language of publication;
2) description of the technique used for sono-HSG:
resolution, two-dimensional (2D) or three-dimensional
(3D) device, vaginal or abdominal probe, type of
contrast, type of catheter, and use of Doppler;
3) measures of diagnostic accuracy of sono-HSG
(and HSG when available) in reference to laparoscopy.
For comparison purposes, we will consider a non-patent
tube as a positive test and data of studies will be converted
if needed. If published data does not allow us to obtain or
derive the number of true positives (TP), false positives
(FP), true negatives (TN) and false negatives (FN), we will
attempt to contact the corresponding author of the study.Assessment of methodological quality
Two reviewers will independently assess the risk of bias
and applicability concerns using a checklist derived from
the Quality Assessment of Diagnostic Accuracy Study 2
(QUADAS-2) tool [25] (web appendix). In case of
discrepancy, a third reviewer will be consulted. An interval
of no more than one month between the tests will be
considered appropriate. Sono-HSG (± HSG) results
must be interpreted without the knowledge of the results
of laparoscopy. However, we will consider the lack of
blinding in the interpretation of laparoscopy results to
be associated with a low potential for bias. Reviewers’
judgments about risks of bias and applicability concerns
will be used in sensitivity analyses to examine the effects
of methodological quality of studies.Outcomes
The primary outcome will be the diagnostic accuracy of
sono-HSG for detecting tubal occlusion. The secondary
outcome will be the direct comparison of the diagnostic
accuracy of sono-HSG and HSG.Statistical analysis and data synthesis
Meta-analyses will be performed by computing TP, TN,
FP, and FN results of each study in bivariate hierarchical
random-effects models using SAS 9.3 (SAS Institute
Inc., Cary, NC, USA, 2011). Cochrane Review Manager
version 5.2 (The Nordic Cochrane Centre, The Cochrane
Collaboration, Copenhagen, Denmark, 2012) will be used
to present the results. Pooled and individual estimates of
sensitivity and specificity and 95% confidence intervals
(CI) will be presented in forest plots. We will generate
summary receiver operating characteristics (SROC) curves
using point estimates for each study as well as a sym-
metrical summary curve, a summary point estimate,
95% confidence region, and 95% prediction region. Direct
comparison of sono-HSG and HSG accuracy will also be
achieved using bivariate models.
The magnitude of heterogeneity will be assessed by
calculating the 95% prediction region on SROC curves
[26]. We will perform sensitivity analyses with bivariate
hierarchical random-effects model and examine the effect
of differences in the technique used for sono-HSG
(2D versus 3D, low (≤ 5 MHz) versus high resolution
(> 5 MHz), use of Doppler, vaginal versus abdominal
probe, Echovist versus saline, and use of a catheter
with balloon versus catheter without balloon), and in
methodological quality of studies (low versus high or
unclear risks of bias and applicability concerns).
Discussion
Assessment of tubal patency is an important part of the
investigation of infertile couples as tubal factors are
responsible for almost one third of cases of female
subfertility [1]. The proposed systematic review is based
on recommended methodological approaches [14,15,25]
and will determine the accuracy of sono-HSG for the
diagnosis of tubal occlusion in women suffering from
subfertility. This review will also permit comparison of
sono-HSG with HSG, the latter being widely used and
accepted as a reliable test for ruling out tubal occlusion
in this population [2,3,27,28].
Maheux-Lacroix et al. Systematic Reviews 2013, 2:50 Page 4 of 5
http://www.systematicreviewsjournal.com/content/2/1/50Previous diagnostic test studies conducted on the subject
have reported variable results, which may be linked to
imprecision or variable methodological quality. Discrep-
ancies may also be associated with differences in the
techniques used for sono-HSG, which have greatly changed
in the past decade with technological developments [11-13].
This systematic review will allow us to determine whether
sono-HSG is an adequate screening test for diagnosing
tubal occlusion. It will also determine if sono-HSG could
replace HSG for the screening of tubal occlusion consider-
ing that sono-HSG is associated with several advantages
over HSG including better diagnostic accuracy for uterine
pathologies [8,9], concomitant assessment of ovaries
and myometrium and avoidance of radiation and risk
of iodine allergy [3]. The systematic review could also
identify specific sono-HSG techniques associated with
greater sensitivity and/or specificity. We plan to commu-
nicate the results of the review by presenting research
abstracts at conferences and by publishing the results in a
peer-reviewed journal.
Web appendix
Quality checklist derived from QUADAS-2 tool
1. Patient selection
a. Risk of bias
 Was a consecutive or random sample of
patients enrolled? Yes, No, Unclear
 Was a case-control design avoided? Yes, No,
Unclear
 Did the study avoid inappropriate exclusion?
Yes, No, Unclear
 Could the selection of patients have
introduced bias? Low, High, Unclear
b. Concern regarding applicability
 Is there concern that the included patients do
not match the review question? Low, High,
Unclear
2. Index tests: hysterosalpingosonography
(sono-HSG) ± hysterosalpingography (HSG)
a. Risk of bias Was the sono-HSG ± HSG results
interpreted without knowledge of the
results of the reference standard?
Yes, No, Unclear
 Was the definition of a positive test pre-
specified? Yes, No, Unclear
 Could the conduct or interpretation of the
sono-HSG ± HSG have introduced bias? Low,
High, Unclear
b. Concern regarding applicability
 Is there concern that sono-HSG ± HSG, its
conduct, or interpretation differs from the
review question? Low, High, Unclear3. Reference standard: laparoscopy with
chromotubation
a. Risk of bias
 Is there a standard likely to correctly classify
the target condition? Yes, No, Unclear
 Could the conduct or interpretation of the
laparoscopy have introduced bias? Low, High,
Unclear
b. Concern regarding applicability
 Is there concern that tubal patency as defined
by the reference standard does not match the
review question? Low, High, Unclear
4. Flow and timing
a. Risk of bias Was there an interval of no more than one
month or one cycle between the index test(s)
and the reference standard? Yes, No, Unclear
 Did patients receive the same reference
standard? Yes, No, Unclear
 Did all patients in the analysis receive the
reference standard? Yes, No, Unclear
 Were at least 90% of eligible patients included
in the analysis? Yes, No, Unclear
 Could the patient flow have introduced bias?
Low, High, UnclearAbbreviations
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